COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign a written consent form agreeing to take part.
- People who have been diagnosed with pre-COPD or COPD (any stage from I to IV) based on the 2023 GOLD guidelines.
- People who have been taking part in pulmonary rehabilitation therapy (a structured breathing and exercise program) for more than three months.
Who may not be able to join:
- People who are under 18 years of age.
- People who have been diagnosed with a neuromuscular disease (a condition affecting the nerves and muscles).
- People who have had a serious worsening of a breathing condition that required emergency care or a hospital stay in the past three months.
- People who are unable to take part in a cardiopulmonary exercise test (a supervised test that measures how the heart and lungs respond to physical activity).
- People who have another illness or physical restriction that has prevented them from taking part in exercise training for more than one year.
- People who a doctor has assessed as having severe malnutrition or a significantly low body weight for their height.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ke-Yun Chao, PhD, Fu Jen Catholic University
Phone: +886-905-301-879
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
interleukin-6
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.